Zydus Lifesciences Share Price
₹896.70
as on
Zydus Lifesciences Stock Performance
as on March 27, 2026 at 9:31 pm IST
Day's Low
Day's High
₹894.00₹910.40
0.30%
Downside
1.53%
Upside
52 Week's Low
52 Week's High
₹795.00₹1,059.0511.34%
Downside
18.11%
Upside
Zydus Lifesciences share price movements today
- Previous Close
- ₹903.70
- Open
- ₹901.95
- Volume
- 9.40L
- Upper Circuit
- ₹994.05
- Lower Circuit
- ₹813.35
- Day's Low - High
- ₹894.00 - ₹910.40
- 52 Week Low - High
- ₹795.00 - ₹1,059.05
Zydus Lifesciences Historical Returns
- 1 Month Return
- -1.12 %
- 3 Month Return
- -0.87 %
- 1 Year Return
- + 2.19 %
- 3 Year Return
- + 82.87 %
- 5 Year Return
- + 106.35 %
Zydus Lifesciences Fundamentals
as on March 27, 2026 at 4:01 pm IST
Market Cap
₹90,229.00 Cr
Return on Equity (ROE)
31.29
PE Ratio (TTM)
18.27
Return on capital employed (ROCE)
30.47
Industry PE ratio
41.43
Beta (LTM)
0.82
P/B Ratio
4.2
Dividend Yield
1.24
PEG Ratio
4.5
Quarterly Earnings Growth YOY
-3.9
EPS (TTM)
45.87
Sector
Pharmaceuticals
Book Value
238.1
Technical Analysis
Bearish
View Technical Analysis
Zydus Lifesciences Stock Valuation
as on March 27, 2026 at 4:01 pm IST
Zydus Lifesciences in the last 5 years
Lowest (7.34x)
March 7, 2022
Today (18.27x)
March 27, 2026
Industry (41.43x)
March 27, 2026
Highest (34.62x)
March 26, 2024
Today’s Price to Earnings Ratio: 18.27x
Zydus Lifesciences Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Zydus Lifesciences with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| HOLD | 90,229.00 | 21.27% | 0.61 | 4,614 | 23,241 | |
| BUY | 7,348.64 | -11.9% | 0.52 | 413 | 2,013 | |
| BUY | 76,328.95 | 10.2% | 0.60 | 3,483 | 31,723 | |
| BUY | 55,536.88 | 14.65% | 0.00 | 1,414 | 6,445 | |
| BUY | 38,277.29 | 11.69% | 0.56 | 927 | 3,749 |
Market expectation of Zydus Lifesciences Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
35.71%
Buy
39.29%
Hold
25.00%
Sell
Zydus Lifesciences Stock’s Investor Sentiment and Interest
Investment in Zydus Lifesciences Ltd Shares on INDmoney has dropped by -14.63% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Zydus Lifesciences Ltd Stock has decreased by -27% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Zydus Lifesciences Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Zydus Lifesciences Ltd Annual Profit & Loss
Figures in Rupees Crores
Zydus Lifesciences Ltd Cash Flow
Figures in Rupees Crores
Zydus Lifesciences Stock Shareholding Pattern
Numbers in percentages
Mutual Funds that own Zydus Lifesciences Stock
Check out the Mutual Funds with significant holdings in Zydus Lifesciences.
Funds | Holdings | Shares Held | |
|---|---|---|---|
 Parag Parikh Flexi Cap Direct Growth | 1.29% | 18853686 | |
 Kotak Flexicap Fund Direct Growth | 1.7% | 10500000 | |
 ICICI Prudential Large Cap Fund Direct Plan Growth | 0.38% | 3228172 | |
ICICI Prudential India Opportunities Fund Direct Growth | 0.46% | 1794293 | |
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth | 2.07% | 1528792 |
Zydus Lifesciences Corporate Actions
View detailed summary of the earnings and dividend history of Zydus Lifesciences.
Zydus Lifesciences Ltd Earnings Results
Zydus Lifesciences Ltd’s net profit jumped 1.82% since last year same period to ₹1,042.10Cr in the Q3 2025-2026. On a quarterly growth basis, Zydus Lifesciences Ltd has generated -17.2% fall in its net profits since last 3-months.
Read More about Earnings ResultsZydus Lifesciences Ltd Dividends May,2025
In the quarter ending March 2025, Zydus Lifesciences Ltd has declared dividend of ₹11.00 per share on 19 May 2025 - translating a dividend yield of 1.23%.
Read More about Dividends
Indices Featuring Zydus Lifesciences Stock
Check stock indices that include Zydus Lifesciences.
Insights on Zydus Lifesciences Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRetail Holding Up
Retail Investor have increased holdings from 6.80% to 6.85% in Dec 2025 quarter
- POSITIVE IMPACT
Promoter Holding Up
Promoters have increased holdings from 74.99% to 75.00% in Dec 2025 quarter
- POSITIVE IMPACT
MF Holding Up
Mutual Funds have increased holdings from 4.70% to 4.71% in Dec 2025 quarter
- POSITIVE IMPACT
Price Rise
In the last 7 days, ZYDUSLIFE stock has moved up by 4.2%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 6.23K Cr → 6.97K Cr (in ₹), with an average increase of 10.7% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Torrent Pharmaceuticals Ltd has given 34.0% return, outperforming this stock by 31.8%
- NO EFFECT
Against Peers
In the last 3 years, Lupin Ltd has given 257.9% return, outperforming this stock by 175.0%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, 1.46K Cr → 1.04K Cr (in ₹), with an average decrease of 15.7% per quarter
- NEGATIVE IMPACT
FII Holding Down
Foreign Institutions have decreased holdings from 7.34% to 7.06% in Dec 2025 quarter
Zydus Lifesciences Stock Futures & Options Contracts
View the latest movement in Zydus Lifesciences Futures & Options, including strike prices, expiry dates, and percentage changes.
Zydus Lifesciences Options
Zydus Lifesciences Futures
About Zydus Lifesciences Ltd
The company has a strong presence in the global market and is known for its high-quality pharmaceutical products. It manufactures a wide range of generic and specialty drugs, including cardiovascular, anti-infective, anti-diabetic, and oncology medicines. Zydus also produces over-the-counter products and nutritional supplements. Some of its top products include Zetia, Atorvastatin, and Metformin.
Zydus Lifesciences Ltd is also known for its popular brands, such as Cadila, Nutralite, and Zydus Wellness. The company has a strong presence in the Indian market, with its products being sold in more than 20,000 stores across the country. It also exports its products to over 100 countries worldwide.
Revenue: ₹6,780.40Cr as on December 2025 (Q3 FY26)
Net Profit: ₹965.10Cr as on December 2025 (Q3 FY26)
Listing date: 18 Apr, 2000
Chairperson Name: Pankaj R Patel
| Organisation | Zydus Lifesciences Ltd |
| Headquarters | Ahmedabad |
| Industry | Pharmaceuticals |
| CEO | Pankaj R Patel |
| E-voting on shares | Click here to vote |
FAQs
What is Zydus Lifesciences share price today?
Zydus Lifesciences share price today stands at ₹896.7 as on at the close of the market. Zydus Lifesciences share today touched a day high of ₹910.4 and a low of ₹894.
What is the 52 week high and 52 week low range for Zydus Lifesciences share?
Zydus Lifesciences touched a 52 week high of ₹1059.05 and a 52 week low of ₹795. Zydus Lifesciences share price today i.e. is closed at ₹896.7, which is -15.33% down from its 52 week high and 12.79% up from its 52 week low.
What is Zydus Lifesciences's market capitalisation today?
Zydus Lifesciences market capitalisation is ₹90,229.00 Cr as on .
How to buy Zydus Lifesciences shares?
To buy Zydus Lifesciences shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for ZYDUSLIFE or Zydus Lifesciences Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Zydus Lifesciences shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Zydus Lifesciences trading volume today?
Zydus Lifesciences trading volume is 9.40L as on . This means that 9.40L shares of Zydus Lifesciences were bought and sold on the stock market during today's trading session.